558 related articles for article (PubMed ID: 19507250)
1. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
2. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Yokoyama A
Leukemia; 2008 Dec; 22(12):2159-68. PubMed ID: 18784743
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Ni L; Koeffler HP; Yokoyama A
Exp Hematol; 2010 Aug; 38(8):666-76. PubMed ID: 20382200
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells.
Kuo HC; Kuo WH; Lee YJ; Wang CJ; Tseng TH
Toxicol Appl Pharmacol; 2006 Oct; 216(1):80-8. PubMed ID: 16766008
[TBL] [Abstract][Full Text] [Related]
6. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
7. [Everolimus combined with all-trans retinoid acid reverses drug resistance in acute promyelocytic leukemia NB4-R1 cells].
Liao WC; He Y; Wang BS; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 44(5):525-31. PubMed ID: 26713527
[TBL] [Abstract][Full Text] [Related]
8. [Effect of aminopeptidase inhibitor on differentiation induction activity of all-trans retinoic acid in human acute promyelocytic leukemia NB4 cells and its mechanism].
Lin MF; Qian XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):471-6. PubMed ID: 16800923
[TBL] [Abstract][Full Text] [Related]
9. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways.
Tamburini J; Chapuis N; Bardet V; Park S; Sujobert P; Willems L; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
Blood; 2008 Jan; 111(1):379-82. PubMed ID: 17878402
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
12. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.
Tamburini J; Green AS; Bardet V; Chapuis N; Park S; Willems L; Uzunov M; Ifrah N; Dreyfus F; Lacombe C; Mayeux P; Bouscary D
Blood; 2009 Aug; 114(8):1618-27. PubMed ID: 19458359
[TBL] [Abstract][Full Text] [Related]
13. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
14. Korean red ginseng extract induces proliferation to differentiation transition of human acute promyelocytic leukemia cells via MYC-SKP2-CDKN1B axis.
Jo S; Lee H; Kim S; Lee CH; Chung H
J Ethnopharmacol; 2013 Nov; 150(2):700-7. PubMed ID: 24095829
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MEK/ERK signaling induces apoptosis of acute myelogenous leukemia cells via inhibition of eukaryotic initiation factor 4E-binding protein 1 and down-regulation of Mcl-1.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
Apoptosis; 2010 Jul; 15(7):795-804. PubMed ID: 20221697
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
17. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
Danilenko M; Wang X; Studzinski GP
J Natl Cancer Inst; 2001 Aug; 93(16):1224-33. PubMed ID: 11504768
[TBL] [Abstract][Full Text] [Related]
18. c-myc but not Hif-1α-dependent downregulation of VEGF influences the proliferation and differentiation of HL-60 cells induced by ATRA.
Song G; Li Y; Zhang Z; Ren X; Li H; Zhang W; Wei R; Pan S; Shi L; Bi K; Jiang G
Oncol Rep; 2013 Jun; 29(6):2378-84. PubMed ID: 23588859
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA.
Liu J; Bi G; Wen P; Yang W; Ren X; Tang T; Xie C; Dong W; Jiang G
Cell Mol Immunol; 2007 Feb; 4(1):59-63. PubMed ID: 17349212
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]